Organicell Regenerative Medicine Inc. (OTCMKTS:OCEL) Stock Jumps: Company Gets Additional Funding of $11 Million

September 12, 2022

Organicell Regenerative Medicine Inc. (OTCMKTS:OCEL), closed on an extra $1 million private stock purchase at $0.04 per share and secured a $10 Million Equity Line of Credit with Tysadco Partners, LLC, as announced on September 09, 2022. The total amount of new funding deals now stands at $16.5 Million. Trading Data On Friday, OCEL stock gained 6.90% to $0.0449 with more than 304.10K shares, compared to its average volume of…